Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I).
about
HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoterHuman T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)Tetraspanins in viral infections: a fundamental role in viral biology?Effect of transforming viruses on molecular mechanisms associated with cancerLack of evidence to support the association of a single IL28B genotype SNP rs12979860 with the HTLV-1 clinical outcomes and proviral load.The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesisExpression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.Molecular epidemiology of simian T-cell lymphotropic virus type 1 in wild and captive sooty mangabeys.Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesisIL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers.Prevalence of human T-cell lymphotropic virus type 1 infection in hospitalized patients with tuberculosis.Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens.Effect of phosphonated carbocyclic 2'-oxa-3'-aza-nucleoside on human T-cell leukemia virus type 1 infection in vitro.Familial transmission of human T-cell lymphotrophic virus: silent dissemination of an emerging but neglected infection.Legislation and informed consent brochures for dental patients receiving amalgam restorations.Role of post-translational modifications of HTLV-1 Tax in NF-κB activation.Molecular characterization of human T-cell lymphotropic virus type 1 full and partial genomes by Illumina massively parallel sequencing technologyEvaluation of the microbicidal activity and cytokines/chemokines profile released by neutrophils from HTLV-1-infected individualsMyocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREBInhibition of geranylgeranyl transferase-I decreases cell viability of HTLV-1-transformed cells.Correlation between LTR point mutations and proviral load levels among human T cell lymphotropic virus type 1 (HTLV-1) asymptomatic carriersCellular Factors Involved in HTLV-1 Entry and PathogenicitEpidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.Expression of parathyroid hormone-related protein during immortalization of human peripheral blood mononuclear cells by HTLV-1: implications for transformation.Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms.Inhibition of cell-to-cell transmission of human T-cell lymphotropic virus type 1 in vitro by carbohydrate-binding agents.The Influence of Coinfection on Mood States in HTLV-1-Infected Patients.The impact of human T-cell lymphotropic virus I infection on clinical and immunologic outcomes in patients coinfected with HIV and hepatitis C virus.Current topics in prevention of human T-cell leukemia virus type i infection: NF-kappa B inhibitors and APOBEC3.Early neurologic abnormalities associated with human T-cell lymphotropic virus type 1 infection in a cohort of Peruvian childrenSeroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of IranRepression of IRF-4 target genes in human T cell leukemia virus-1 infection.Incidence of adult T-cell leukemia/lymphoma in nonendemic areas.Truncated MTA-1: a pitfall in ELISA-based immunoassay of HTLV-1 infectionLevels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.Development of [Ile⁴⁰]HTLV-I protease inhibition assay using novel fluorogenic and chromogenic substrate.HAM/TSP: association between white matter lesions on magnetic resonance imaging, clinical and cerebrospinal fluid findings.Ocular lesions in HTLV-1 infected patients from Salvador, State of Bahia: the city with the highest prevalence of this infection in Brazil.Impairment of the humoral and CD4(+) T cell responses in HTLV-1-infected individuals immunized with tetanus toxoid.Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
P2860
Q21134702-C7AC26EB-D3A5-4CE8-B983-15AB8A6FBB9DQ24805664-58BCFEEE-B477-4481-9361-ADE71B91D322Q27470936-5480026F-4C34-48AC-8FCF-6D72CA97C091Q28273926-724FAA7F-A0B7-4F41-A556-CC6C306326C5Q31109635-88CDABEF-6985-4196-8D06-320F25B63383Q33355836-78F4C5E6-BC61-49E6-847D-D5B47AB7350DQ33707390-F24393CC-01BE-4DAE-8B3B-4894851D499AQ33781184-517751B4-6E96-41EA-A6EB-D90A9412A376Q33969941-B551FD72-1711-41C5-A230-297A84AFC77FQ34214760-7345B2F8-A7FA-4BC7-A015-89353DDF51A7Q34236033-23532ED8-E9B4-4CFC-87A1-AB127F7E5A37Q34601530-92549C5B-1CCE-47C4-BFB0-4A491C1284FBQ34707606-B5059D03-CBF8-476A-9F00-732B738909BFQ34779059-13365E2C-2B3B-4324-86F5-C0E2243681CCQ34839189-7B41DFBE-59BA-4D32-9AB9-B6C9E747EAF0Q34878458-06E6A7F8-3082-453A-8B27-DE2FDED4C7DFQ35136041-5EA7E640-95ED-4820-89A9-3C0C7A2A1688Q35157490-0EA5E2BC-41A7-4433-8937-A51AB8C18244Q35218631-36617102-0A13-4B4F-93D8-888E5E924492Q35491663-BBB35209-94F8-454F-85E2-3641550E5489Q35780796-2669BAC8-59C6-43E9-BAD8-D1044D81817AQ36049779-1EED31B5-0EF7-4821-90C3-7D968E19F024Q36072562-18989B20-9A6A-4550-914F-EFE8DC2A6089Q36731297-3BDDEB70-DFA3-4C57-8DA2-54A845AE5251Q36771229-77281288-5905-482C-93B8-FE84F067AEB1Q36804058-BBD503B4-37DB-4E2A-8A8C-7F97E8EF435FQ36857397-83363F7E-542F-44AD-AC14-8DA255F3AD0EQ37104439-61127B9C-425C-47CD-80CB-21516BE0BE49Q37198681-D1171806-C62E-4ACC-9C67-FBA8CFE998D4Q37394120-AF94D02D-7ED0-4319-8DFE-E7BB44A843DEQ37615618-454ADBFA-5E69-4406-8E76-C864F8B3F87BQ38362324-17552A9D-38FC-4207-913B-9ABBD4A66F5FQ38374407-B07582BD-20D6-47EF-8914-E96180DEFD2FQ38852729-5902F1C6-D63D-4FF3-8E16-7E06C4C25A5CQ39035579-11409115-2BA5-47E2-8269-15D6B8DBA0D6Q39150767-AA84864E-96E1-4D0C-8377-1563547EC262Q39370445-505DD880-8FF6-4951-A79A-FDD05D3E1646Q39385699-A3A40158-0951-48FC-8F57-DDC0188C08FEQ39481246-2B5D8A00-45B2-4FAD-8B8F-22FD3B1FE30CQ39527582-098E6890-C10D-4960-A44C-62F8262F95A2
P2860
Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I).
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I).
@ast
Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I).
@en
type
label
Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I).
@ast
Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I).
@en
prefLabel
Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I).
@ast
Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I).
@en
P2093
P1476
Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I).
@en
P2093
Arnette JA
Williams FM
P304
P356
10.1016/S0736-4679(99)00173-0
P577
2000-01-01T00:00:00Z